HEINE develops OMEGA 500 breath shield, in response to Ophthalmic bodies’ guidance





Harlow, UK – 24th July 2020 - John Weiss & Son, the leading manufacturer and distributor of gold-standard ophthalmic micro-surgical instruments and procedures, is pleased to announce that a breath shield has been exclusively developed for the OMEGA 500 indirect ophthalmoscope.

In light of the COVID-19 pandemic, users of binocular indirect ophthalmoscopes are facing challenges when it comes to examining patients. Ophthalmic societies are advising that examiners attach breath shields to their ophthalmic devices to reduce their potential risk of infection.

The OMEGA 500 lightweight breath shield covers the mouth, nose and chin area. It offers a clear view through the ophthalmoscope during examinations, thanks to a cut-out in the optics.

Easy to attach to the instrument, the breath shield allows comfortable working, as there is no contact with the wearer’s nose and all the controls on the ophthalmoscope are freely accessible. The OMEGA 500 can be charged directly on the EN 50 UNPLUGGED wall-mounted charging station while the breath shield remains attached.

The OMEGA 500 breath shield is available to purchase online now from John Weiss’ sister company Haag-Streit UK at https://hsuk.co/omega500breathshield.

For more information on the HEINE range, please visit https://jweiss.co/heine or call 01279 883858.

Press release distributed by Pressat on behalf of John Weiss & Son, on Monday 27 July, 2020. For more information subscribe and follow https://pressat.co.uk/


Ophthamoscope OMEGA 500 Breath Shield COVID-19 Infection Control Health Manufacturing, Engineering & Energy Medical & Pharmaceutical
Published By

John Weiss & Son

John Weiss & Son
01279 883858
rseymour@johnweiss.com
https://www.haag-streit.com/john-weiss/
Visit Newsroom

Media

* For more information regarding media usage, ownership and rights please contact John Weiss & Son.

Additional PR Formats


You just read:

HEINE develops OMEGA 500 breath shield, in response to Ophthalmic bodies’ guidance